GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...

Analyst Graham Parry of Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), retaining the ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial.

They were “really good results,” said Chief Commercial Officer Luke Miels in an interview. GSK had been developing mRNA flu and COVID-19 shots with its partner CureVac, but earlier this year ...

Alume Biosciences is pleased to announce the appointment of Rick Gonzalez as Chief Commercial Officer. With over three ...

So, what are the reasons for the commercial success of GSK's future blockbuster? The answer is quite simple and lies in the fact that there remains an extremely high demand for it both as a ...

GSK (LSE: GSK) announced full results from its SWIFT-1 and SWIFT-2 Phase III trials for depemokimab, an ultra-long-acting ...